CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 104 enrolled
Drug / intervention
Mindfulness-based stress reductionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03526523
NCT03526523N/ACompleted

Testing the Efficacy of Mindfulness-based Stress Reduction as a Prophylactic Intervention in the Prevention of Perimenopausal Depression: a Randomized Trial

University of Regina·interventional·Posted May 16, 2018·Updated Jan 6, 2021

In Brief

A clinical study evaluating Mindfulness-based stress reduction for Perimenopausal Depression and Depressive Symptoms. Completed, enrolled 104 participants across 1 site.

Detailed Summary

Depression is the leading cause of disability worldwide and a risk factor for other diseases. While women are at elevated risk for depression in general, the menopause transition is a particularly vulnerable time for many women, with the risk for depression increasing 2-4 fold. The objective of this research study is to determine whether mindfulness-based stress reduction (MBSR), an 8-week structured intervention involving meditation and yoga, has any beneficial mood effects for women undergoing this vulnerable time.

Study Details

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 16, 2018
Enrollment StartJul 5, 2018
Primary CompletionMar 20, 2020
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.1 years ago

Interventions

Mindfulness-based stress reductionbehavioral

8 weekly 2.5-hour group sessions of mindfulness based stress reduction, led by a certified MBSR instructor